Abstract:Abstract In the early stages of diabetic retinopathy (DR), diabetes-related hyperglycemia directly inhibits the AKT signaling pathway by increasing oxidative stress or inhibiting growth factor expression, which leads to retinal cell apoptosis, nerve proliferation and fundus microvascular disease. However, due to compensatory vascular hyperplasia in the late stage of DR, the vascular endothelial growth factor (VEGF)/phosphatidylinositol 3 kinase (PI3K)/AKT cascade is activated, resulting in opposite levels of AKT regulation compared with the early stage. Studies have shown that many factors, including insulin, insulin-like growth factor-1 (IGF-1), VEGF and others, can regulate the AKT pathway. Disruption of the insulin pathway decreases AKT activation. IGF-1 downregulation decreases the activation of AKT in DR, which abrogates the neuroprotective effect, upregulates VEGF expression and thus induces neovascularization. Although inhibiting VEGF is the main treatment for neovascularization in DR, excessive inhibition may lead to apoptosis in inner retinal neurons. AKT pathway substrates, including mammalian target of rapamycin (mTOR), forkhead box O (FOXO), glycogen synthase kinase-3 (GSK-3)/nuclear factor erythroid 2-related factor 2 (Nrf2), and nuclear factor kappa-B (NF-κB), are a research focus. mTOR inhibitors can delay or prevent retinal microangiopathy, whereas low mTOR activity can decrease retinal protein synthesis. Inactivated AKT fails to inhibit FOXO and thus causes apoptosis. The GSK-3/Nrf2 cascade regulates oxidation and inflammation in DR. NF-κB is activated in diabetic retinas and is involved in inflammation and apoptosis. Many pathways or vital activities, such as the Janus kinase (JAK)/signal transducer and activator of transcription (STAT) and mitogen-activated protein kinase (MAPK) signaling pathways, interact with the AKT pathway to influence DR development. Numerous regulatory methods can simultaneously impact the AKT pathway and other pathways, and it is essential to consider both the connections and interactions between these pathways. In this review, we summarize changes in the AKT signaling pathway in DR and targeted drugs based on these potential sites.

Study progress of HIF-1 regulation mechanisms in diabetic retinopathy and neuropathy

Inflammatory Machenism in the Pathogenesis of Diabetic Retinopathy

Advances of Regulation of Endoplasmic Reticulum Stress and HIF-1 to VEGF in Diabetic Retinopathy

Hypoxia-inducible factor-1α: A promising therapeutic target for vasculopathy in diabetic retinopathy

Advance on the relationship between HIF-1α and angiogenesis deficiency in diabetes

Research Progress on Mitochondrial Dysfunction in Diabetic Retinopathy

Research progress in regulatory factors of ischemia-reperfusion injury induced by diabetic retinopathy

The current status and progress of the pathological changes and related molecular mechanisms of neuroretinal injury in diabetic retinopathy

The Oxidative Stress and Mitochondrial Dysfunction during the Pathogenesis of Diabetic Retinopathy

Expression and Significance of HIF-1 Α and VEGF in Rats with Diabetic Retinopathy

Research Progress and Therapeutic Prospect of Angiogenesis Inhibitors in the Microvascular Complication of Diabetic Mellitus

Effect Of Hif-1 Alpha, Vegf And Mvd Expression On Angiogenesis In Diabetic Nephropathy

The Possible Mechanisms Underlying The Impairment Of Hif-1 Alpha Pathway Signaling In Hyperglycemia And The Beneficial Effects Of Certain Therapies

Molecules related to diabetic retinopathy in the vitreous and involved pathways

High-glucose Induced HIF-1α Down-Regulation Impairs the Function of the Endothelial Progenitor Cells Via PI3K/AKT Signaling Pathway

Advance of neurodegeneration in diabetic retinopathy

Hypoxia-Inducible Factor-1α Target Genes Contribute to Retinal Neuroprotection.

An overview of the pathogenesis of diabetic retinopathy

Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target

O-GlcNAcylation under Hypoxic Conditions and Its Effects on the Blood-Retinal Barrier in Diabetic Retinopathy

Mechanistic insights into the alterations and regulation of the AKT signaling pathway in diabetic retinopathy